应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01228 北海康成-B
休市中 07-11 16:08:03
0.740
+0.060
+8.82%
最高
0.740
最低
0.620
成交量
640.70万
今开
0.710
昨收
0.680
日振幅
17.65%
总市值
3.14亿
流通市值
3.14亿
总股本
4.25亿
成交额
439.40万
换手率
1.51%
流通股本
4.25亿
市净率
-0.61
ROE
-281.91%
每股收益
-1.14
52周最高
0.850
52周最低
0.095
市盈率
-0.65
股息
0.00
股息收益率
0.00
ROA
-83.11%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
北海康成-B07月11日主力净流入11.6万元 散户资金抛售
市场透视 · 07-11 08:16
北海康成-B07月11日主力净流入11.6万元 散户资金抛售
北海康成-B07月10日主力净流出310.3万元 散户资金买入
市场透视 · 07-10 08:15
北海康成-B07月10日主力净流出310.3万元 散户资金买入
北海康成再涨近35%公司积极准备戈芮宁医保谈判并推动该产品出海进程
动脉网 · 07-08
北海康成再涨近35%公司积极准备戈芮宁医保谈判并推动该产品出海进程
生物医药B类股走强,基石药业-B涨超10%
老虎资讯综合 · 07-08
生物医药B类股走强,基石药业-B涨超10%
港股异动 | 北海康成-B(01228)盘中再涨43% 戈芮宁开出首张处方 戈谢病患者年治疗费用有望下降50%
智通财经 · 07-07
港股异动 | 北海康成-B(01228)盘中再涨43% 戈芮宁开出首张处方 戈谢病患者年治疗费用有望下降50%
北海康成-B07月03日主力净流入16.7万元 散户资金抛售
市场透视 · 07-03
北海康成-B07月03日主力净流入16.7万元 散户资金抛售
港股异动 | 北海康成-B(01228)盘中涨超24% 戈谢病新药开出首张处方 公司称正积极准备国家医保谈判
智通财经网 · 07-03
港股异动 | 北海康成-B(01228)盘中涨超24% 戈谢病新药开出首张处方 公司称正积极准备国家医保谈判
戈谢病新药开出首张处方,北海康成独家回应:正积极准备国谈
时代财经 · 07-03
戈谢病新药开出首张处方,北海康成独家回应:正积极准备国谈
北海康成-B委任赵玮为非执行董事
格隆汇资讯 · 06-30
北海康成-B委任赵玮为非执行董事
北海康成-B06月18日主力净流出46.6万元 散户资金买入
市场透视 · 06-18
北海康成-B06月18日主力净流出46.6万元 散户资金买入
港股生物医药股盘初活跃,北海康成-B涨超6%
老虎资讯综合 · 06-18
港股生物医药股盘初活跃,北海康成-B涨超6%
北海康成-B06月17日获主力加仓23.7万元
市场透视 · 06-17
北海康成-B06月17日获主力加仓23.7万元
港股异动 | 北海康成-B(01228)再涨超43% 旗下戈芮宁获批上市 有望较现有疗法降价超50%
智通财经 · 06-16
港股异动 | 北海康成-B(01228)再涨超43% 旗下戈芮宁获批上市 有望较现有疗法降价超50%
北海康成-B(01228)上涨10.77%,报0.36元/股
金融界 · 06-16
北海康成-B(01228)上涨10.77%,报0.36元/股
北海康成-B盘中涨超31% 近期注射用维拉苷酶β获国家药监局授予上市批准
智通财经 · 06-13
北海康成-B盘中涨超31% 近期注射用维拉苷酶β获国家药监局授予上市批准
北海康成-B05月26日主力净流入8.0万元 散户资金抛售
市场透视 · 05-26
北海康成-B05月26日主力净流入8.0万元 散户资金抛售
北海康成-B05月21日主力净流出9.1万元 散户资金买入
市场透视 · 05-21
北海康成-B05月21日主力净流出9.1万元 散户资金买入
北海康成-B(01228):注射用维拉苷酶β(戈芮宁,CAN103)在中国获批上市
智通财经 · 05-20
北海康成-B(01228):注射用维拉苷酶β(戈芮宁,CAN103)在中国获批上市
北海康成-B05月19日主力净流入8.4万元 散户资金抛售
市场透视 · 05-19
北海康成-B05月19日主力净流入8.4万元 散户资金抛售
罕见病患者迎新药,北海康成戈谢病药物在华获批
时代财经 · 05-16
罕见病患者迎新药,北海康成戈谢病药物在华获批
加载更多
公司概况
公司名称:
北海康成-B
所属市场:
SEHK
上市日期:
2021-12-10
主营业务:
北海康成制药有限公司是一家主要从事罕见病疗法的研发和商业化的中国公司。该公司的主营业务是医疗产品的开发、生产、推广及销售。该公司的主要产品是用于治疗胶质母细胞瘤(GBM)的糖基化融合蛋白CAN008。该公司的产品主要用于亨特氏综合症(MPS II)等罕见病、罕见肿瘤等领域。该公司还从事基因疗法的开发。
发行价格:
12.180
{"stockData":{"symbol":"01228","market":"HK","secType":"STK","nameCN":"北海康成-B","latestPrice":0.74,"timestamp":1752221283030,"preClose":0.68,"halted":0,"volume":6407000,"delay":0,"floatShares":424838320,"shares":424838320,"eps":-1.1400478046517468,"marketStatus":"休市中","change":0.06,"latestTime":"07-11 16:08:03","open":0.71,"high":0.74,"low":0.62,"amount":4393970,"amplitude":0.176471,"askPrice":0.74,"askSize":56000,"bidPrice":0.73,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":-1.1400478046517468,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752456600000},"marketStatusCode":7,"adr":0,"listingDate":1639065600000,"exchange":"SEHK","adjPreClose":0.68,"openAndCloseTimeList":[[1752197400000,1752206400000],[1752210000000,1752220800000]],"volumeRatio":0.2741079832304018,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01228","defaultTab":"news","newsList":[{"id":"2550368919","title":"北海康成-B07月11日主力净流入11.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2550368919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550368919?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:16","pubTimestamp":1752221764,"startTime":"0","endTime":"0","summary":"07月11日, 北海康成-B股价涨8.82%,报收0.74元,成交金额439.4万元,换手率1.51%,振幅17.65%,量比0.27。北海康成-B今日主力资金净流入11.6万元,上一交易日主力净流出310.3万元。该股近5个交易日上涨111.59%,主力资金累计净流入210.3万元;近20日主力资金累计净流入420.5万元,其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711171116a6a37473&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711171116a6a37473&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2550837617","title":"北海康成-B07月10日主力净流出310.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2550837617","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550837617?lang=zh_cn&edition=full","pubTime":"2025-07-10 16:15","pubTimestamp":1752135351,"startTime":"0","endTime":"0","summary":"07月10日, 北海康成-B股价跌1.45%,报收0.68元,成交金额951.6万元,换手率3.28%,振幅21.74%,量比0.63。北海康成-B今日主力资金净流出310.3万元,上一交易日主力净流入491.7万元。该股近5个交易日上涨89.04%,主力资金累计净流入238.4万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入404.6万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710170039a44232ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710170039a44232ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2549515824","title":"北海康成再涨近35%公司积极准备戈芮宁医保谈判并推动该产品出海进程","url":"https://stock-news.laohu8.com/highlight/detail?id=2549515824","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549515824?lang=zh_cn&edition=full","pubTime":"2025-07-08 15:32","pubTimestamp":1751959920,"startTime":"0","endTime":"0","summary":"北海康成-B股价大涨,戈芮宁获批上市并开出首方,公司准备医保谈判并计划推动产品出海。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708153712979e07b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708153712979e07b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"1141327845","title":"生物医药B类股走强,基石药业-B涨超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1141327845","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141327845?lang=zh_cn&edition=full","pubTime":"2025-07-08 09:34","pubTimestamp":1751938452,"startTime":"0","endTime":"0","summary":"周二生物医药B类股走强,生物医药B类股走强,$基石药业-B$涨超10%,与欧洲Gentili达成独家战略合作,$荣昌生物$涨近6%,$加科思$涨近4%,$北海康成-B$涨超3%,$云顶新耀$、$和铂医药-B$、$复宏汉霖$涨超2%,$亚盛医药$、歌礼制药、$心玮医疗-B$涨超1%。基石药业-B发布公告,基石药业与一家专注肿瘤领域,并在欧洲市场深耕百年的生物医药公司 Istituto Gentili就舒格利单抗在西欧和英国的商业化达成独家战略合作。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952","02616","BK1161","BK1574","01228","09995","01167"],"gpt_icon":0},{"id":"2549585678","title":"港股异动 | 北海康成-B(01228)盘中再涨43% 戈芮宁开出首张处方 戈谢病患者年治疗费用有望下降50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549585678","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549585678?lang=zh_cn&edition=full","pubTime":"2025-07-07 15:48","pubTimestamp":1751874502,"startTime":"0","endTime":"0","summary":"消息面上,据时代财经报道,从北海康成获悉,其戈谢病一类创新药“戈芮宁”开出首张处方,今日首位患者已在新华医院接受治疗。今年5月13日,该药物在中国获批上市,用于12岁及以上青少年和成人I型和Ⅲ型戈谢病患者长期酶替代治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1314583.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"港股异动 | 北海康成-B(01228)盘中再涨43% 戈芮宁开出首张处方 戈谢病患者年治疗费用有望下降50%","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01228","BK1161"],"gpt_icon":1},{"id":"2548808884","title":"北海康成-B07月03日主力净流入16.7万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2548808884","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548808884?lang=zh_cn&edition=full","pubTime":"2025-07-03 16:15","pubTimestamp":1751530551,"startTime":"0","endTime":"0","summary":"07月03日, 北海康成-B股价涨17.74%,报收0.36元,成交金额241.9万元,换手率1.71%,振幅33.87%,量比2.13。北海康成-B今日主力资金净流入16.7万元,上一交易日主力净流出0万元。该股近5个交易日上涨8.96%,主力资金累计净流出22.7万元;近20日主力资金累计净流入175.1万元,其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703170733a4ccfe76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703170733a4ccfe76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2548755188","title":"港股异动 | 北海康成-B(01228)盘中涨超24% 戈谢病新药开出首张处方 公司称正积极准备国家医保谈判","url":"https://stock-news.laohu8.com/highlight/detail?id=2548755188","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548755188?lang=zh_cn&edition=full","pubTime":"2025-07-03 15:50","pubTimestamp":1751529003,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,北海康成-B盘中涨超24%,截至发稿,涨19.35%,报0.37港元,成交额227.11万港元。消息面上,据时代财经报道,从北海康成获悉,其戈谢病一类创新药“戈芮宁”开出首张处方,今日首位患者已在新华医院接受治疗。今年5月13日,该药物在中国获批上市,用于12岁及以上青少年和成人I型和Ⅲ型戈谢病患者长期酶替代治疗。就是否参与今年国家医保谈判,北海康成表示正在积极准备。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1313514.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"港股异动 | 北海康成-B(01228)盘中涨超24% 戈谢病新药开出首张处方 公司称正积极准备国家医保谈判","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2548066826","title":"戈谢病新药开出首张处方,北海康成独家回应:正积极准备国谈","url":"https://stock-news.laohu8.com/highlight/detail?id=2548066826","media":"时代财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548066826?lang=zh_cn&edition=full","pubTime":"2025-07-03 12:02","pubTimestamp":1751515352,"startTime":"0","endTime":"0","summary":"本文来源:时代财经7月3日,时代财经从北海康成(01228.HK)获悉,其戈谢病一类创新药“戈芮宁”开出首张处方,今日首位患者已在新华医院接受治疗。今年5月13日,该药物在中国获批上市,用于12岁及以上青少年和成人I型和Ⅲ型戈谢病患者长期酶替代治疗。就是否参与今年国家医保谈判,北海康成对时代财经表示,正在积极准备。(时代财经 张羽岐)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070312040897981e3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070312040897981e3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2547984013","title":"北海康成-B委任赵玮为非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2547984013","media":"格隆汇资讯","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547984013?lang=zh_cn&edition=full","pubTime":"2025-06-30 22:53","pubTimestamp":1751295183,"startTime":"0","endTime":"0","summary":"格隆汇6月30日丨北海康成-B(01228.HK)宣布,赵玮已获委任为非执行董事及董事会薪酬委员会成员,自2025年6月30日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506302253089794b90a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506302253089794b90a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2544297851","title":"北海康成-B06月18日主力净流出46.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2544297851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544297851?lang=zh_cn&edition=full","pubTime":"2025-06-18 16:15","pubTimestamp":1750234555,"startTime":"0","endTime":"0","summary":"06月18日, 北海康成-B股价跌3.75%,报收0.39元,成交金额415.9万元,换手率2.56%,振幅27.50%,量比0.37。北海康成-B今日主力资金净流出46.6万元,上一交易日主力净流入23.7万元。该股近5个交易日上涨128.40%,主力资金累计净流入182.4万元;近20日主力资金累计净流入262.9万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618174340a4b046de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618174340a4b046de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"1145997195","title":"港股生物医药股盘初活跃,北海康成-B涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1145997195","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145997195?lang=zh_cn&edition=full","pubTime":"2025-06-18 09:39","pubTimestamp":1750210788,"startTime":"0","endTime":"0","summary":"6月18日,港股生物医药股盘初活跃,$北海康成-B(01228)$涨超6%,$科济药业-B(02171)$涨近6%,$加科思-B(01167)$涨超5%,$复宏汉霖(02696)$、$歌礼制药-B(01672)$涨超4%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167","02171","01228"],"gpt_icon":0},{"id":"2544996345","title":"北海康成-B06月17日获主力加仓23.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544996345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544996345?lang=zh_cn&edition=full","pubTime":"2025-06-17 16:15","pubTimestamp":1750148144,"startTime":"0","endTime":"0","summary":"06月17日, 北海康成-B股价涨5.26%,报收0.40元,成交金额440.7万元,换手率2.66%,振幅22.37%,量比0.38。北海康成-B今日主力资金净流入23.7万元,连续3日净流入,上一交易日主力净流入157.0万元。该股近5个交易日上涨123.46%,主力资金累计净流入204.3万元;近20日主力资金累计净流入300.3万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617173610a4ae00df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617173610a4ae00df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2543649355","title":"港股异动 | 北海康成-B(01228)再涨超43% 旗下戈芮宁获批上市 有望较现有疗法降价超50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543649355","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543649355?lang=zh_cn&edition=full","pubTime":"2025-06-16 11:09","pubTimestamp":1750043389,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,北海康成-B再涨超43%,月内累计涨幅已超250%。消息面上,北海康成5月底宣布,公司旗下注射用维拉苷酶β获批上市,适用于12岁及以上青少年和成人I型和Ⅲ型戈谢病患者的长期酶替代治疗。公开资料显示,在戈芮宁获批之前,国内一共有3款获批上市的治疗药物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1305530.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"港股异动 | 北海康成-B(01228)再涨超43% 旗下戈芮宁获批上市 有望较现有疗法降价超50%","news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2543464805","title":"北海康成-B(01228)上涨10.77%,报0.36元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2543464805","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543464805?lang=zh_cn&edition=full","pubTime":"2025-06-16 09:41","pubTimestamp":1750038117,"startTime":"0","endTime":"0","summary":"6月16日,北海康成-B(01228)盘中上涨10.77%,截至09:41,报0.36元/股,成交226.76万元。北海康成制药有限公司是一家专注于罕见疾病领域的全球化生物制药公司,拥有10个药物资产组合,包括2个上市产品和8个在研药物。公司致力于创新疗法的研究和开发,尤其在基因治疗和罕见病领域,与全球领先的研究机构和生物技术公司展开合作。截至2024年年报,北海康成-B营业总收入8510.3万元、净利润-4.43亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/16094151086278.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2543636575","title":"北海康成-B盘中涨超31% 近期注射用维拉苷酶β获国家药监局授予上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2543636575","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543636575?lang=zh_cn&edition=full","pubTime":"2025-06-13 11:16","pubTimestamp":1749784579,"startTime":"0","endTime":"0","summary":"北海康成-b(01228)盘中涨超31%,截至发稿,涨31.71%,报0.27港元,成交额548.79万港元。消息面上,北海康成-B发布公告,注射用维拉苷酶β(戈芮宁,CAN103)已于2025年5月15日获中国国家药品监督管理局授予上市批准,用于治疗I型及III型戈谢病。公司持有开发及商业化产品的全球专有权利。据介绍,戈芮宁是国内首个自主研发适用于12岁及以上青少年和成人I型及III型戈谢病患者的长期酶替代疗法。作为一类创新药,其可完全替代同类进口产品,将大大提升国内患者用药的可及性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613112501a7069211&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613112501a7069211&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2538742271","title":"北海康成-B05月26日主力净流入8.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2538742271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538742271?lang=zh_cn&edition=full","pubTime":"2025-05-26 16:15","pubTimestamp":1748247350,"startTime":"0","endTime":"0","summary":"05月26日, 北海康成-B股价涨1.50%,报收0.14元,成交金额64.1万元,换手率1.13%,振幅6.02%,量比1.18。北海康成-B今日主力资金净流入8.0万元,上一交易日主力净流出0万元。该股近5个交易日下跌3.57%,主力资金累计净流出1.1万元;近20日主力资金累计净流出14.8万元,其中净流出天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250526173336a6ed5816&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250526173336a6ed5816&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2537988926","title":"北海康成-B05月21日主力净流出9.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2537988926","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537988926?lang=zh_cn&edition=full","pubTime":"2025-05-21 16:15","pubTimestamp":1747815315,"startTime":"0","endTime":"0","summary":"05月21日, 北海康成-B股价跌2.16%,报收0.14元,成交金额48.8万元,换手率0.85%,振幅7.91%,量比1.01。北海康成-B今日主力资金净流出9.1万元,上一交易日主力净流出0万元。该股近5个交易日下跌2.16%,主力资金累计净流出0.7万元;近20日主力资金累计净流出22.8万元,其中净流出天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521171843a486907a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521171843a486907a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2536669915","title":"北海康成-B(01228):注射用维拉苷酶β(戈芮宁,CAN103)在中国获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2536669915","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536669915?lang=zh_cn&edition=full","pubTime":"2025-05-20 12:28","pubTimestamp":1747715318,"startTime":"0","endTime":"0","summary":"智通财经APP讯,北海康成-B 发布公告,注射用维拉苷酶β已于2025年5月15日获中国国家药品监督管理局授予上市批准,用于治疗I型及III型戈谢病。临床上戈谢病包括0型、I型、II型和III型,其中I型和III型戈谢病患者多能活到成年。戈芮宁是国内首个自主研发适用于12岁及以上青少年和成人I型及III型戈谢病患者的长期酶替代疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1295192.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"北海康成-B(01228):注射用维拉苷酶β(戈芮宁,CAN103)在中国获批上市","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01228","BK1161"],"gpt_icon":1},{"id":"2536507357","title":"北海康成-B05月19日主力净流入8.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2536507357","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536507357?lang=zh_cn&edition=full","pubTime":"2025-05-19 16:15","pubTimestamp":1747642535,"startTime":"0","endTime":"0","summary":"05月19日, 北海康成-B股价涨1.45%,报收0.14元,成交金额76.6万元,换手率1.29%,振幅17.39%,量比3.70。北海康成-B今日主力资金净流入8.4万元,上一交易日主力净流出0万元。该股近5个交易日上涨9.38%,主力资金累计净流出16.8万元;近20日主力资金累计净流出13.7万元,其中净流出天数为2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519173247a483d4c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519173247a483d4c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2535599333","title":"罕见病患者迎新药,北海康成戈谢病药物在华获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2535599333","media":"时代财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535599333?lang=zh_cn&edition=full","pubTime":"2025-05-16 09:41","pubTimestamp":1747359716,"startTime":"0","endTime":"0","summary":"本文来源:时代财经时代财经从北海康成获悉,5月16日,北海康成对外宣布其全资子公司北海康成(上海)生物科技有限公司为持有人的注射用维拉苷酶β(商品名:戈芮宁)获国家药品监督管理局批准上市。戈芮宁是国内首个本土自主研发适用于12岁及以上青少年和成人I型和Ⅲ型戈谢病患者的长期酶替代治疗,属一类创新药并可替代同类进口产品,将大大提升国内患者用药可及。在商业化方面,北海康成对时代财经表示,这一药物的获批,或大大降低戈谢病患者的年治疗费用。(时代财经 张羽岐)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516094227975b3c21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516094227975b3c21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ssitimber.com.hk","stockEarnings":[{"period":"1week","weight":1.1449},{"period":"1month","weight":3.5679},{"period":"3month","weight":3.2286},{"period":"6month","weight":5.1667},{"period":"1year","weight":0.9733},{"period":"ytd","weight":4.5639}],"compareEarnings":[{"period":"1week","weight":0.0093},{"period":"1month","weight":-0.0093},{"period":"3month","weight":0.1542},{"period":"6month","weight":0.2662},{"period":"1year","weight":0.3537},{"period":"ytd","weight":0.2034}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北海康成制药有限公司是一家主要从事罕见病疗法的研发和商业化的中国公司。该公司的主营业务是医疗产品的开发、生产、推广及销售。该公司的主要产品是用于治疗胶质母细胞瘤(GBM)的糖基化融合蛋白CAN008。该公司的产品主要用于亨特氏综合症(MPS II)等罕见病、罕见肿瘤等领域。该公司还从事基因疗法的开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.179215},{"month":2,"riseRate":0.25,"avgChangeRate":0.001379},{"month":3,"riseRate":0.25,"avgChangeRate":-0.105397},{"month":4,"riseRate":0.25,"avgChangeRate":-0.006446},{"month":5,"riseRate":0,"avgChangeRate":-0.117685},{"month":6,"riseRate":0.25,"avgChangeRate":0.256405},{"month":7,"riseRate":0.5,"avgChangeRate":0.348726},{"month":8,"riseRate":0,"avgChangeRate":-0.144107},{"month":9,"riseRate":0.666667,"avgChangeRate":0.167938},{"month":10,"riseRate":0,"avgChangeRate":-0.130297},{"month":11,"riseRate":0,"avgChangeRate":-0.292964},{"month":12,"riseRate":0.333333,"avgChangeRate":0.002113}],"exchange":"SEHK","name":"北海康成-B","nameEN":"CANBRIDGE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"北海康成-B(01228)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供北海康成-B(01228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"北海康成-B,01228,北海康成-B股票,北海康成-B股票老虎,北海康成-B股票老虎国际,北海康成-B行情,北海康成-B股票行情,北海康成-B股价,北海康成-B股市,北海康成-B股票价格,北海康成-B股票交易,北海康成-B股票购买,北海康成-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"北海康成-B(01228)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供北海康成-B(01228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}